Solid Biosciences Inc. (SLDB)

Solid Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	138.93	80.24	74.02	155.38	119.14	154.74
Short-Term Investments	129.18	68.69	49.63	58.34	88.64	-
Cash & Short-Term Investments	268.11	148.92	123.64	213.72	207.78	154.74
Cash Growth	40.91%	20.45%	-42.15%	2.86%	34.27%	85.27%
Receivables	-	-	-	-	0.11	-
Prepaid Expenses	3.3	1.65	2.11	3	8.71	1.48
Other Current Assets	7.24	6.73	3.98	2.91	6.02	2.67
Total Current Assets	278.64	157.3	129.73	219.64	222.61	158.9
Property, Plant & Equipment	27.45	29.04	33.16	38.61	7.6	11.73
Other Long-Term Assets	2.2	2.32	2.04	2.01	2.16	0.54
Total Assets	308.29	188.66	164.94	260.25	232.38	171.17
Accounts Payable	4.7	4.24	2.03	3.24	4.46	3.27
Accrued Expenses	16.55	19.85	10.16	16.69	9.53	8.64
Current Portion of Leases	2.9	3.02	2.32	2.57	1.5	2.21
Current Unearned Revenue	-	-	-	-	8.08	10.36
Other Current Liabilities	5.7	3.15	-	0.01	0.04	-
Total Current Liabilities	29.85	30.26	14.52	22.51	23.6	24.48
Long-Term Leases	20.16	21.16	23.94	25.98	0.57	2.94
Long-Term Unearned Revenue	-	-	-	-	-	10.36
Other Long-Term Liabilities	-	-	-	0.1	-	1.3
Total Liabilities	50	51.42	38.46	48.59	24.17	39.08
Common Stock	0.08	0.04	0.02	0.02	0.01	0.09
Additional Paid-In Capital	1,120	920.61	785.2	774.45	685.01	536.57
Retained Earnings	-862.21	-783.45	-658.75	-562.74	-476.76	-404.57
Comprehensive Income & Other	-0.04	0.05	0.02	-0.07	-0.05	-
Total Common Equity	258.29	137.25	126.48	211.67	208.21	132.09
Shareholders' Equity	258.29	137.25	126.48	211.67	208.21	132.09
Total Liabilities & Equity	308.29	188.66	164.94	260.25	232.38	171.17
Total Debt	23.05	24.18	26.27	28.55	2.06	5.15
Net Cash (Debt)	245.06	124.74	97.38	185.18	205.72	149.59
Net Cash Growth	48.55%	28.11%	-47.41%	-9.98%	37.52%	95.66%
Net Cash Per Share	4.00	3.06	4.90	21.75	28.90	43.20
Filing Date Shares Outstanding	77.87	77.49	37.76	19.57	7.36	5.68
Total Common Shares Outstanding	77.6	40.47	20.39	19.56	7.36	5.66
Working Capital	248.79	127.05	115.22	197.13	199.01	134.42
Book Value Per Share	3.33	3.39	6.20	10.82	28.30	23.34
Tangible Book Value	258.29	137.25	126.48	211.67	208.21	132.09
Tangible Book Value Per Share	3.33	3.39	6.20	10.82	28.30	23.34
Machinery	-	16.1	17.92	17.96	11.37	10.27
Construction In Progress	-	0.88	0.41	1.72	1.49	1.33
Leasehold Improvements	-	0.47	0.48	0.38	4.71	4.71

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q